Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RAR{alpha} Dependency Targetable by SY-1425, a Potent and Selective RAR{alpha} Agonist [Research Articles]

This article is highlighted in the In This Issue feature, p. 1047

Source: Cancer Discovery - October 2, 2017 Category: Cancer & Oncology Authors: McKeown, M. R., Corces, M. R., Eaton, M. L., Fiore, C., Lee, E., Lopez, J. T., Chen, M. W., Smith, D., Chan, S. M., Koenig, J. L., Austgen, K., Guenther, M. G., Orlando, D. A., Loven, J., Fritz, C. C., Majeti, R. Tags: Research Articles Source Type: research